Recovering from COVID-19 (ReCOV): Feasibility of an Allied-Health-Led Multidisciplinary Outpatient Rehabilitation Service for People with Long COVID

Aruska N. D’Souza, Myvanwy Merrett, Hilda Griffin, An Tran-Duy, Carly Struck, Timothy N. Fazio, Genevieve Juj, Catherine L. Granger and Casey L. Peiris ()
Additional contact information
Aruska N. D’Souza: Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia
Myvanwy Merrett: Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia
Hilda Griffin: Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia
An Tran-Duy: Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC 3010, Australia
Carly Struck: Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia
Timothy N. Fazio: Health Intelligence Unit, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia
Genevieve Juj: Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia
Catherine L. Granger: Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia
Casey L. Peiris: Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia

IJERPH, 2024, vol. 21, issue 7, 1-14

Abstract: Background: A multidisciplinary approach is required for the management of long COVID. The aim of this study was to determine the feasibility (demand, implementation, practicality, acceptability, and limited efficacy) of an allied-health-led multidisciplinary symptom management service (ReCOV) for long COVID. Methods: A single-group observational cohort feasibility study was conducted to determine demand (referrals), acceptability (survey), implementation (waitlist times, health professions seen), practicality (adverse events), and limited efficacy (admission and discharge scores from the World Health Organization Disability Assessment Scale, Brief Illness Perception Questionnaire (BIPQ), Patient Health Questionnaire, and EuroQol 5D-5L). Data are presented as median [interquartile range] or count (percentage). Results: During the study, 143 participants (aged 42.00 [32.00–51.00] years, 68% women) participated in ReCOV. Participants were waitlisted for 3.86 [2.14–9.86] weeks and engaged with 5.00 [3.00–6.00] different health professionals. No adverse events occurred. The thematic analysis revealed that ReCOV was helpful but did not fully meet the needs of all participants. Limited efficacy testing indicated that participants had improved understanding and control ( p < 0.001) of symptoms (BIPQ) and a small improvement in EQ VAS score (median difference 5.50 points [0.00–25.00], p = 0.004]). Conclusions: A multidisciplinary service was safe and mostly acceptable to participants for the management of long COVID. Further research should investigate the clinical and cost effectiveness of such a service, including optimal service duration and patient outcomes.

Keywords: post-acute COVID-19 syndrome; outpatients; feasibility studies (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/21/7/958/pdf (application/pdf)
https://www.mdpi.com/1660-4601/21/7/958/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:21:y:2024:i:7:p:958-:d:1440187

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().